Compassionate use: Putting drug regulations to the test
When should pharmaceutical companies grant compassionate use of experimental treatments? How readily available should the drugs be? A PBS news segment considers these issues.
When should pharmaceutical companies give gravely ill patients access to experimental treatments? The above news segment offers an good summary of the issues involved in this vexed ethical dilemma.
Compassionate Use Putting drug regulations to the test
Xavier Symons
https://www.bioedge.org/images/2008images/TH_savejosh.jpg
Creative commons
clinical trials
compassionate use
Xavier Symons is a bioethicist and scholar in residence at the Kennedy Institute for Ethics at Georgetown University.
Latest posts by Xavier Symons (see all)
- Can machines be moral? - March 7, 2021
- Can we synthesise Christianity moral theology with secular bioethics? - November 28, 2020
- Euthanasia polling data may fail to capture people’s considered views - August 15, 2020
More Stories
Commercial surrogacy hammered in Rome
Momentum in growing in Europe for a global ban on surrogacy. Italy’s Prime Minister, Giorgia Meloni has blasted surrogacy as...
Canadian man wins right to a government-funded ‘penile-preserving vaginoplasty’
An Ontario man has won the right to government-funded gender-affirming surgery in the United States which will give him both...
14-year-olds will be able to change their gender legally in Germany
German lawmakers have made it easier for transgender, intersex and non-binary people to change their official gender. A controversial Self-Determination...
Gaza’s IVF embryos have been destroyed by Israeli bombs
One of the many casualties of the war in Gaza has been the embryos and gametes stored at the Al-Basma IVF...
UK doctors fear toxic abuse over their research on trans issues
Fallout from the Cass review of transgender medical treatment in the UK continues. The Guardian interviewed doctors and researchers who...
Utah’s new stem cell law undermines FDA’s authority
The state of Utah has just enacted a law permitting patients to receive medical treatments using placental stem cells without formal approval...
